Genesis Biotechnology Group has completed the acquisition of PharmOptima, which will enable the former to provide its customers a single point-of-contact for the development and co-ordination of their unique pre-clinical drug development programme.

"Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma."

The acquirer company is a US-based biotechnology firm, whereas the target company is a contract research organisation also based in the US.

Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma.

Both companies involved in the transaction are pharmaceutical organisations based in China.

The purchase consideration for the acquisition is expected to be ¥371.6m ($54.08m).

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Clinical Trials Arena Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now